Sign In

Eric Lewis

Safety Development Leader at GlaxoSmithKline

Eric Lewis is a seasoned professional with extensive experience in the clinical development of drugs targeting metabolic diseases across Phases I to III.

He has a strong background in conducting Thorough QTc studies and handling Safety Biomarkers like troponin I & T.

Eric Lewis pursued his Doctor of Medicine (MD) degree at the University of Michigan Medical School, solidifying his medical expertise.

He has held key positions at GlaxoSmithKline, including Safety Development Leader, Director of Clinical Pharmacology and Discovery Medicine, as well as Medical Advisor & Manager.

With a rich background in pharmaceutical development and safety assessment, Eric Lewis is a valuable asset in the field of clinical research and drug development.

E
Add to my network

Location

Raleigh-Durham, North Carolina Area